Cited by 469Cardiovascular Function and Risk FactorsHeart Failure Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

The Development of Heart Failure in Patients With Diabetes Mellitus and Pre-Clinical Diastolic Dysfunction

Open access
From, Aaron M., Scott, Christopher G., Chen, Horng H.·2010·Journal of the American College of Cardiology

Abstract

Objectives The purpose of this study was to evaluate the outcomes of pre-clinical diastolic dysfunction in diabetic patients.Background Studies have reported a high prevalence of pre-clinical diastolic dysfunction among patients with diabetes mellitus.Methods We identified all diabetic patients with a tissue Doppler imaging assessment of diastolic function in Olmsted County, Minnesota, from 2001 to 2007. Diastolic dysfunction was defined as a passive transmitral left ventricular (LV) inflow velocity to tissue Doppler imaging velocity of the medial mitral annulus during passive filling (E/e') ratio >15. The main outcome was the development of heart failure (HF). Secondary outcomes were the development of atrial fibrillation and death.Results Overall, 1,760 diabetic patients with a tissue Doppler echocardiographic assessment of diastolic function were identified; 411 (23%) patients had diastolic dysfunction. Using multivariable Cox's proportional hazard modeling, we determined that for every 1-U increase in the passive transmitral LV inflow velocity to tissue Doppler imaging velocity of the medial mitral annulus during passive filling (E/e') ratio, the hazard ratio (HR) of HF increased by 3% (HR: 1.03; 95% confidence interval [CI]: 1.01 to 1.06; p = 0.006) and that diastolic dysfunction was associated with the subsequent development of HF after adjustment for age, sex, body mass index, hypertension, coronary disease, and echocardiographic parameters (HR: 1.61; 95% CI: 1.17 to 2.20; p = 0.003). The cumulative probability of the development of HF at 5 years for diabetic patients with diastolic dysfunction was 36.9% compared with 16.8% for patients without diastolic dysfunction (p < 0.001). Furthermore, diabetic patients with diastolic dysfunction had a significantly higher mortality rate compared with those without diastolic dysfunction.Conclusions We demonstrated that an increase in the passive transmitral LV inflow velocity to tissue Doppler imaging velocity of the medial mitral annulus during passive filling (E/e') ratio in diabetic patients is associated with the subsequent development of HF and increased mortality independent of hypertension, coronary disease, or other echocardiographic parameters.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2009.12.003

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Diabetic patients with subclinical diastolic dysfunction have a 5-year mortality rate of 30.8% compared to 12.1% for diabetic patients with no diastolic dysfunction.

    “Diabetic patients with subclinical diastolic dysfunction have a 5-year mortality rate of 30.8% compared to 12.1% for diabetic patients with no diastolic dysfunction [4].”

    From Role of Serum Biomarkers in Early Detection of Diabetic Cardiomyopathy in the West Virginian Population (2016) · cites this paper as [4]

    The Discussion (page unavailable) says preclinical diastolic dysfunction in diabetic patients was associated with increased mortality, supporting the direction of the comparison. The retrieved Results passages do not give the claimed five-year mortality rates of 30.8% and 12.1%; a separate Results passage gives five-year rates for heart failure, not death. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Diabetic cardiomyopathy (DCM) is an established complication of diabetes mellitus.

    “Diabetic cardiomyopathy (DCM) is an established complication of diabetes mellitus.”

    From Role of Serum Biomarkers in Early Detection of Diabetic Cardiomyopathy in the West Virginian Population (2016) · cites this paper as [4]

    The Introduction describes diabetic cardiomyopathy as a proposed primary myocardial disease, rather than calling it an established complication. The Discussion and Conclusion report that preclinical diastolic dysfunction is prevalent in patients with diabetes, which supports an associated cardiac abnormality but not the stronger claim about diabetic cardiomyopathy. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Diastolic dysfunction is a strong predictor of incident HF and CV mortality in T2DM.

    “Furthermore, the diastolic dysfunction is a strong predictor of incident HF and CV mortality in T2DM [81,82].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
From, A. M., Scott, C. G., & Chen, H. H.
Affiliations
Mayo Clinic (US)
Corresponding author
Chen, Horng H.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2010-01
Volume
55
Issue
4
Pages
300-305
ISSN
0735-1097 (ISSN-L)
OpenAlex
W50284947
Cited by
469
References
28
Citations by year
2026: 17 · 2025: 21 · 2024: 26 · 2023: 26 · 2022: 30 · 2021: 30 · 2020: 37 · 2019: 40 · 2018: 30 · 2017: 37 · 2016: 35 · 2015: 37 · 2014: 31 · 2013: 20 · 2012: 21
FWCI
15.38
Type
journal article
Language
en
Update notices
erratum (2010-11-02)
Open access
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (HL 76611-04-P4)
  • national Institute of Arthritis, Musculoskeletal and Skin Diseases (R01-AR30582)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
diabetes mellitus, E/e' ratio, tissue Doppler imaging, left ventricular diastolic function, mortality, atrial fibrillation
MeSH terms
Aged, Atrial Fibrillation, Female, Humans, Male, Middle Aged, Echocardiography, Doppler, Ventricular Dysfunction, Left, Diabetes Complications, Heart Failure, Diastolic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review